Teva Expands Respiratory Pipeline with MicroDose Therapeutx Purchase
By Heather Cartwright
Pharma Deals Review: Vol 2013 Issue 7 (Table of Contents)
Published: 5 Jul-2013
DOI: 10.3833/pdr.v2013.i7.1961 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Teva Pharmaceutical Industries has agreed to acquire MicroDose Therapeutx and its proprietary inhalation technologies for US$40 M upfront and up to US$125 M in post-acquisition milestones...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS